» Articles » PMID: 18836476

MicroRNAs: Key Players in the Immune System, Differentiation, Tumorigenesis and Cell Death

Overview
Journal Oncogene
Date 2008 Oct 7
PMID 18836476
Citations 340
Authors
Affiliations
Soon will be listed here.
Abstract

Micro (mi)RNAs are small, highly conserved noncoding RNAs that control gene expression post-transcriptionally either via the degradation of target mRNAs or the inhibition of protein translation. Each miRNA is believed to regulate the expression of multiple mRNA targets, and many miRNAs have been linked to the initiation and progression of human cancer. miRNAs control various activities of the immune system and different stages of hematopoietic development, and their misexpression is the cause of various blood malignancies. Certain miRNAs have oncogenic activities, whereas others have the potential to act as tumor suppressors. Because they control fundamental processes such as differentiation, cell growth and cell death, the study of the role of miRNAs in human neoplasms holds great promise for novel forms of therapy. Here, we summarize the role of miRNAs and their targets in contributing to human cancers and their function as regulators of apoptotic pathways and the immune system.

Citing Articles

From actinic keratosis to cutaneous squamous cell carcinoma: the key pathogenesis and treatments.

Li Z, Lu F, Zhou F, Song D, Chang L, Liu W Front Immunol. 2025; 16:1518633.

PMID: 39925808 PMC: 11802505. DOI: 10.3389/fimmu.2025.1518633.


Exosomes and microRNAs as mediators of the exercise.

Li H, Liu G, Wang B, Momeni M Eur J Med Res. 2025; 30(1):38.

PMID: 39828711 PMC: 11742998. DOI: 10.1186/s40001-025-02273-4.


Expression of some circulating microRNAs as predictive biomarkers for prognosis and treatment response in glioblastoma.

Ali E, Ahmed M, Shawki M, El Arab L, Khalifa M, Swellam M Sci Rep. 2025; 15(1):1933.

PMID: 39809835 PMC: 11733229. DOI: 10.1038/s41598-024-83800-x.


Biological functions and therapeutic potential of CKS2 in human cancer.

Lai Y, Lin Y Front Oncol. 2024; 14:1424569.

PMID: 39188686 PMC: 11345170. DOI: 10.3389/fonc.2024.1424569.


Exosomal miR-106a-5p derived from intermittently hypoxic non-small-cell lung cancer increases tumor malignancy.

Ren J, Jin Z, Huang Y Physiol Rep. 2024; 12(15):e16157.

PMID: 39085755 PMC: 11291016. DOI: 10.14814/phy2.16157.